A method is described by which the growth inhibitory effects of cytotoxic compounds and fermentation broth cultures on adherent tumor cell lines can be quantitated.
A method is described by which the growth inhibitory effects of cytotoxic compounds and fermentation broth cultures on adherent tumor cell lines can be quantitated.
Cells are seeded into 96-well microtiter plates and 16 hours later the test compounds or broths are added to the wells. Cell growth is measured after three days (B16 mouse melanoma cells) or six days (HT-29, human colon carcinoma cells) by first fixing adherent cells, staining with Giemsa stain, washing away excess stain, then solubilizing stained cells with HCl. Absorbance is determined using a microELISA spectrophotometer and the data are transferred to and analyzed by a computer. The assay is rapid and reproducible and can be used to identify fermentation broths with cytotoxic components.
Addition of DNA into the assay mixture (cells plus compound) inhibits the cytotoxic activities of certain DNA-reactive agents. The results of this study demonstrate the application of this assay system for primary and secondary evaluation of fermentation broths for in vitro antitumor activity. In this report we describe the approach, results with standard agents and results from the random screening of natural products of unknown character. We also describe a rapid procedure of identifying agents that are cytotoxic and bind to DNA in this assay.
Materials and Methods
Cell Lines B16 (F10) mouse melanoma4) and HT-29 human colon carcinoma cells5) were used in this study and maintained as monolayer cultures in Minimal Essential Media (MEM) (Grand Island Biological Co., Grand Island, NY) supplemented in 10 % calf serum, 1 % penicillin-streptomycin in a 5 % CO2 humidified incubator at 37°C. They were passaged in 75 cm2 tissue culture flasks and were subcultured weekly using Versene to harvest the cells. Cells used in these studies were shown to be free of mycoplasma by the fluorescent Hoechst 33258 staining method of CHEN6).
Drugs and Fermentation Broths and Their Preparation
Daunorubicin, mitomycin C, cycloheximide, vincristine, vinblastine, 5-fluorouracil, rifamycin were purchased from Sigma Chemical Co., St. Louis, MO. Actinomycin D was purchased from Calbiochem-Behring, La Jolla, CA. Bleomycin, phleomycin and talisomycin were generously provided by Bristol Laboratories, Syracuse, NY. All other compounds were generously provided by the National Cancer Institute, Bethesda, MD.
All compounds were first solubilized in DMSO at a concentration of 1 mg/ml and were then diluted to the appropriate concentrations in MEM.
Samples of 200 randomly selected crude broths were obtained from fermentation of various soil microorganisms. Crude culture broths were centrifuged at 10,000 x g for 30 minutes to separate mycelia. The resulting clarified broths were stored at 4°C and assayed within 48 hours. Dilutions of the fermentation broths were made in MEM. Partial characterization of a selected group of broths was achieved by their antimicrobial profile and physico-chemical characteristics. 7, 8, 9) This system has been developed for the identification of known antibiotics within fermentation broths evaluated in our natural products screening program.
Cytotoxicity Assays in 96-Well Microtiter Plates Cells were harvested from monolayers and centrifuged at 1,000 x g for 5 minutes and resuspended in MEM. The cell concentration was determined by hemocytometer counting and the cells were then diluted in MEM to the appropriate cell concentration.
Three thousand (B16) and four thousand (HT-29) cells in 0.1 ml were pipetted into the wells of 96-well microtiter plates (Linbro) using a 5-ml repetitive pipette (Tridak, Brookfield Centrer, CT). Medium without cells was added to one well per plate to serve as spectrophotometric blanks. Plates containing cells were incubated for 16 hours before the addition of drugs or fermentation broths. Drug or fermentation broth at twice the required final concentration was added (0.1 ml) to three wells. Sequential two-fold dilutions were then performed by progressively transferring 0.1 ml of media (in triplicate) using a 40-channel micropipet ("Titertek", Flow Laboratories).
Controls (no drug) included appropriate dilutions of media containing the ethanol and DMSO solvent solutions. Cultures were then continued for a further 3 (B16) or 6 (HT-29) days.
In experiments in which calf thymus DNA was incubated with the cells in the presence of drugs or fermentation broth, the following modifications were made. The cells were added to the wells in a volume of 75 pl. Before the addition of the test compound, 25 ul of calf thymus DNA (2.6 mg/ml) in MEM was added to each well. The final concentration of the DNA in each well during the assay was 325 ,ug/ml. The calf thymus DNA (type I; highly polymerized, Sigma Chemical Co., St. Louis, MO) was prepared as follows. Five mg/ml of DNA was first dissolved in sterile H2O and solubilized overnight at 4°C. In order to reduce the potential for nuclease and bacterial contamination, the DNA solution was boiled for 20 minutes and then cooled at 22°C for 18 hours. Aliquots were stored at -70°C. Immediately before use in an assay, the DNA solution was thawed and diluted to 2.6 mg/ml in MEM.
Following the appropriate incubation period, culture supernatants were aspirated and the cells were washed one time with 0.1 ml of phosphate buffered saline (PBS) and aspirated. One-tenth ml of absolute methanol was added to each well for 10 minutes at room temp to fix the cells. The methanol was then removed and 0.1 ml of Giemsa stain (lot 720559, Fisher Scientific Co., Fairlawn, NJ) (1 stain: 10 saline) was added for 5 minutes to stain the cells and was then aspirated. Cells were washed with 0.2 ml of H2O to remove unbound stain. Stained cells were solubilized with 0.2 ml of 0.1 N HCl. Plates were placed in a microtiter plate shaker apparatus for 10~20 minutes to allow for thorough mixing of the stain into the HCl. Absorbances were read by a microELISA (MR580, Dynatech, Alexandria, Va) at a sample wavelength of 600 nm and a reference wavelength of 405 nm. The data were transferred directly into an Apple II Plus computer for analysis. Data were displayed as total absorbance and percent of the control absorbances (relative to untreated cells).
Drug potency is described by the IC50, the concentration of drug required to reduce the absorbance to 50°0 of that in control cultures (drug-free). Fermentation broth potency is described by the ID50, the dilution of the clarified broth required to reduce the absorbance by 50% of that in control cultures.
Monolayer Clonogenic Assay Cells were harvested and replated at 5,000 cell/plate in sterile 60 mm x 15 mm plates. Plates were incubated for 16 hours to allow attachment of cells to the plate surface. The treatment protocol was as follows. Culture medium was aspirated and 5 ml of culture media containing a drug or fermentation broth was added to cells. Plates were incubated for 3 days at 37°C in a CO, incubator; the media was then removed and 3 ml of fresh media was added to the plates which were then incubated for 2 days. Viability was measured by the ability of a cell to form a colony greater than 50 cells. Colonies wer efixed with 0.5% crystal violet in 95% ethanol. Plates were dried and counted with a Biotran III Automatic Count Totalizer (New Brunswick Scientific Co, Edison, NJ). Means and standard deviations of triplicate samples were determined for each drug concentration.
The data were analyzed by plotting the log of the survival fraction (number of colonies in drug treated plates/number of colonies in controls) versus the drug concentration. relationships between absorbance and cell number illustrates the importance of developing standard curves for all cell lines used in this assay.
Figs. 3A and 3B show the concentration-response curves for six known antitumor agents against B16 cells. Note that the potency of each agent varied and that different drugs produced different types of concentration-response curves. These curves were highly reproducible and the standard error in the absorbance measured between triplicate wells at each concentration was from 1 to 10%. In Figs The sensitivity of B16 cells to a number of the compounds in the microtiter assay was compared to the sensitivities measured in a clonogenic assay (see Materials and Methods). As shown in Table 1 , 10 out 11 compounds had lower IC50 values against B16 cells when measured in the clonogenic assay than in the microtiter plate assay. The increase in sensitivity for the clonogenic assay relative to the microtiter plate assay was less than two-fold for 9 out of 10 compounds. The rank order potencies To determine the utility of the microtiter assay for screening natural products, 200 fermentation broths were tested for cytotoxicity. Fig. 4 shows the percentage of the total broths displaying activity as a function of the dilution. Approximately 90% of these randomly selected cultures displayed cytotoxic activity at dilutions at and below 1: 80. Clearly, the assay is sensitive and using a cut off ID,, dilution at and above 1: 160 to identify cultures with cytotoxic activity probably represents an appropriate compromise between sensitivity and nonspecific cytotoxicity (i.e. false positives). Fig. 5 shows the dose-responses obtained when 6 broths were tested in the microtiter assay against B16 cells. The ID,, dilutions for these broths ranged from 1: 600 to greater than 1: 100,000.
Another potential advantage of the microtiter assay that derives from the small volumes employed and the sensitivity of the assay is that specific antagonists can be efficiently employed to identify agents with particular biochemical targets. For example, we have defined assay conditions which allow for the identification of cytotoxic compounds with DNA-binding characteristics. Specifically, compounds
were incubated with cells in the absence or in the presence of 325 µg/ml of calf thymus DNA. As shown in Fig. 6A , the IC50 for rhodomycin B was increased from 0.8 ng/ml to 0.65 µg/ml (an 800-fold difference)
when it was assayed in the microtiter cytotoxicity assay in the absence or presence of 325 jig/ml calf thymus DNA, respectively. The addition of DNA into the incubation mixture also decreased the cytotoxic potency of daunorubicin and gilvocarcin V (Figs. 6B and 6C ), although the degree of the inhibition of cytotoxicity by DNA differed with each to the three agents ( Table 2 ).
The addition of DNA did not however, alter the shapes or slopes of the linear portions of the doseresponse curves. Fig. 6D shows that the cytotoxic potency of vincristine was not affected by the addition of DNA into the assay system. Table 2 shows that the addition of DNA dramatically reduced the potency of agents that reportedly bind to DNA such as actinomycin D and echinomycin and had no effect on drugs that do not bind to DNA significantly, e.g. rifamycin. Furthermore, partially characterized culture broths containing components of classes of known DNA binding agents were affected similarly by DNA in the assay. Note that the broth AAJO04 which was found to contain virenomycins V and M, a gilvocarcin congener, was the least affected of the broths tested. This correlates with the data obtained using a purified sample of the related antibiotic, gilvocarcin V.
Discussion
Primary screening of fermentation broths for potential antitumor activity requires assay procedures which allow for the evaluation of large numbers of samples (200~1,000 per week) with a reproducible end-point obtained within relatively short period (3~7 days). The assay described in this paper fits these criteria and in addition, it is highly sensitive, reproducible and automatable. Moreover, as the final determination is simply the absorption at 600 nm with a microELISA spectrophotometer, the assay can easily be incorporated into numerous laboratory automation systems, assuring rapid, efficient data storage, retrieval and comparative data analysis.
FINLAY et al.10) have reported on a similar type of cytotoxicity assay employing adherent cell lines grown in 24-and 96-well plates. Similar to that demonstrated in our report, these authors concluded that the method was reproducible and offered the advantage that any adherent cell line could be used without the need for tedious cell counting procedures. Our studies go beyond these initial findings to further demonstrate that the microtiter plate cytotoxicity assay is nearly equivalent in terms of sensitivity to the clonogenic cell assay system, which is used routinely to assess the cytotoxic potency of antitumor agents.11) The comparative data for B16 and HT-29 cells also demonstrate no dramatic differences in their respective sensitivities to the 11 agents studied. Therefore, use of B16 melanoma cells in the microtiter plate system would appear to be a primary screening protocol of appropriate sensitivity and assay duration. Use of a slower growing human neoplastic cell line (HT-29) and tumor cells of defined resistance patterns (to known antitumor agents) in the assay, may be useful in secondary evaluation of cultures originally selected in the primary protocol. Our present study extends these findings in an attempt to use the assay procedure as a screening system to 1) detect fermentation broth cultures which contain molecules with cytotoxic activity and 2) to identify the biochemical properties of these cytotoxic components.
While cytotoxicity is an important activity for a presumptive antineoplatic agent, the identification of the mechanism by which it produces its cytotoxic effects would aid in determining its potential for activity against human neoplasias. For example, the vast majority of clinically useful antineoplastic agents produce their cytotoxic effects through interaction with DNA or interference with DNA metabolism.12) Therefore, screening systems designed to aid in the identification of specific mechanistic classes of agents are valuable when evaluating compound sources such as fermentation broths. In our studies we have identified a system whereby the cytotoxic potencies of known DNA reactive antitumor agents are inhibited in the presence of double-stranded calf thymus DNA. Similar inhibitory effects by calf thymus DNA were observed when broth cultures (partially characterized as containing members of known classes of DNA reactive cytotoxic agents) were evaluated for cytotoxic activity. Although in our studies we employed a heterogeneous preparation of DNA (calf thymus) to inhibit DNA binding agents, other inhibitors could also be used such as homogeneous preparations of DNA (e.g. poly dA-dT), specific nucleosides, sugars, amino acids, etc. Such screening protocols would be of utility not only in identifying specifically desired mechanistic classes of cytotoxic agents but also in identifying undesired classes of cytotoxic agents; allowing one to disregard such broths rapidly and efficiently.
In conclusion, this study demonstrates the practical application of a mammalian cell cytotoxicity assay which employs microtiter plates, automatic spectrophotometric quantitation and the capacity for complete automation. The system is highly adaptable to the use of multiple cell types and varying assay protocols. This microtiter plate cytotoxicity assay procedure may 1) be useful in primary and secondary screening protocols for fermentation broths programs; 2) serve as a biological assay for following the isolation of cytotoxic agents in broths and 3) be used in mechanism of action studies.
